Logo
x

Search

Subscribe Now

initiation

Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

  • October 25, 2021
PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan for Dedifferentiated Liposarcoma

PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan f...

  • August 23, 2021
Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)

Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)

  • June 9, 2021
GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

  • March 17, 2021
Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

  • February 26, 2021
AMO Pharma Initiates P-II REACH-CDM study of AMO-02 (tideglusib) to treat Congenital Myotonic Dystrophy

AMO Pharma Initiates P-II REACH-CDM study of AMO-02 (tideglusib) to treat Congenital Myotonic Dystrophy

  • December 23, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.